Catalyst
Slingshot members are tracking this event:
Tagrisso demonstrated superior progression-free survival compared to standard platinum-based chemotherapy, with a safety profile consistent with previous trials
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AZN |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 18, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Egfr T790m, Tagrisso, Metastatic Nsclc, Phase Iii Aura3 Trial, Egfr T790m Lung Cancer Patients, Egfr-tki
